Search Results (ABSTRACTS)

User ID:
Password:

Search Results (ABSTRACTS)

SharedUniverse Book Store

CES 2006 Highlights

Central Park Gates

Google Earth Blog

Selected Stent Abstracts

Search

Enter Search Term:

Advanced Search

	Advanced Search
[author: SCHOMIG A]

97 Records Found

Title
Authors

Source
Pub. Year

A randomized trial comparing the hand-mounted JoStent with the premounted Multi-Link Duet stent in patients with coronary artery disease.
MEHILLI J, KASTRATI A, DIRSCHINGER J, DOTZER F, SCHUHLEN H, FLECKENSTEIN M, NEUMANN FJ, SCHOMIG A

MEDLINE
2001

Comparative analysis of stent placement versus balloon angioplasty in small coronary arteries with long narrowings (the Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries [ISAR-SMART] Trial).
HAUSLEITER J, KASTRATI A, MEHILLI J, DOTZER F, SCHUHLEN H, DIRSCHINGER J, SCHOMIG A

MEDLINE
2002

Proteolysis of tissue factor pathway inhibitor-1 by thrombolysis in acute myocardial infarction.
OTT I, MALCOUVIER V, SCHOMIG A, NEUMANN FJ

MEDLINE
2002

Comparison of stenting with balloon angioplasty for lesions of small coronary vessels in patients with diabetes mellitus.
MEHILLI J, KASTRATI A, DIRSCHINGER J, DOTZER F, PACHE J, HAUSLEITER J, KRAMER W, SCHUHLEN H, SCHOMIG A

MEDLINE
2002

Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial.
KASTRATI A, MEHILLI J, DIRSCHINGER J, SCHRICKE U, NEVERVE J, PACHE J, MARTINOFF S, NEUMANN FJ, NEKOLLA S, BLASINI R, SEYFARTH M, SCHWAIGER M, SCHOMIG A

MEDLINE
2002

Clopidogrel therapy in patients undergoing coronary stenting: value of a high-loading-dose regimen.
PACHE J, KASTRATI A, MEHILLI J, GAWAZ M, NEUMANN FJ, SEYFARTH M, HALL D, BRAUN S, DIRSCHINGER J, SCHOMIG A

MEDLINE
2002

Early resolution of ST-segment elevation correlates with myocardial salvage assessed by Tc-99m sestamibi scintigraphy in patients with acute myocardial infarction after mechanical or thrombolytic reperfusion therapy.
DONG J, NDREPEPA G, SCHMITT C, MEHILLI J, SCHMIEDER S, SCHWAIGER M, SCHOMIG A, KASTRATI A

MEDLINE
2002

Statin treatment following coronary artery stenting and one-year survival.
SCHOMIG A, MEHILLI J, HOLLE H, HOSL K, KASTRATI D, PACHE J, SEYFARTH M, NEUMANN FJ, DIRSCHINGER J, KASTRATI A

MEDLINE
2002

Predictive factors for early cardiac events and angiographic restenosis after coronary stent placement in small coronary arteries.
HAUSLEITER J, KASTRATI A, MEHILLI J, SCHUHLEN H, PACHE J, DOTZER F, DIRSCHINGER J, SCHOMIG A

MEDLINE
2002

Predictors for thrombotic events within the first month after stent placement in small coronary arteries
MEHILLI J., SCHOMIG A., KASTRATI A., PACHE J., HAUSLEITER J., SCHUHLEN H., DIRSCHINGER J.

ESC 2002
2002

Angiotensin-converting enzyme (ACE) inhibitor treatment of patients with the ACE DD genotype and effect on restenosis after coronary stent placement
KOCH W., VON BECKERATH N., MEHILLI J., SCHOMIG A., KASTRATI A., EHRENHAFT A., EICHINGER M.

ESC 2002
2002

Early ST-segment resolution correlates with myocardial salvage in patients with acute myocardial infarction treated with stenting or thrombolysis
MEHILLI J., SCHOMIG A., KASTRATI A., NDREPEPA G., DONG J., SCHWAIGER M., SCHMIEDER S., SCHMITT C.

ESC 2002
2002

Effect of stent design an strut thickness on long-term outcome of coronary stent placement. Results from the ISAR-STEREO-2 trial
MEHILLI J., SCHOMIG A., KASTRATI A., PACHE J., DOTZER F., SCHUHLEN H., DIRSCHINGER J., SATTELBERGER U.

ESC 2002
2002

Predictors of late mortality after successful coronary stent placement
MEHILLI J., SCHOMIG A., KASTRATI A., HAUSLEITER J., SCHUHLEN H., DIRSCHINGER J., EIMANNSBERGER V., HOLLE H.

ESC 2002
2002

Lesion complexity makes differences in stent performance evident: lessons from the randomized ISAR-STEREO trial
MEHILLI J., SCHOMIG A., KASTRATI A., PACHE J., DOTZER F., HAUSLEITER J., SCHUHLEN H., DIRSCHINGER J.

ESC 2002
2002

Smoking and restenosis after coronary artery stenting: the artefact of smoker's paradox
MEHILLI J., SCHOMIG A., KASTRATI A., BOLLWEIN H., PACHE J., POGATSA-MURRAY G., DOTZER F.

ESC 2002
2002

FcgammaRIIa-R-H131 polymorphism is associated with the formation of restenosis after coronary stenting
KOCH W., VON BECKERATH N., MEHILLI J., SCHOMIG A., KASTRATI A., GORCHAKOVA O., EHRENHAFT A., WITTMANN H.P.

ESC 2002
2002

Apolipoprotein E genotype predicts the clinical outcome after coronary artery stenting
KOCH W., LATZ W., VON BECKERATH N., GRIESSER K., MEHILLI J., SCHOMIG A., KASTRATI A.

ESC 2002
2002

Apolipoprotein E Genotype Predicts the Outcome After Coronary Artery Stenting
KASTRATI ADNAN, MEHILLI JULINDA, SCHOMIG ALBERT, KOCH WERNER, VON BECKERATH NICOLAS, EHRENHAFT ANGELA, LATZ WOLFGANG, GRIESSER KORINNA, EICHINGER MARIANNE

ACC 2002
2002

Age Dependent Impact of the 894 TT Genotype of the Endothelial Nitric Oxide Synthase on the Outcome in Men Following Coronary Stent Placement
KASTRATI ADNAN, MEHILLI JULINDA, SCHOMIG ALBERT, GORCHAKOVA OLGA, KOCH WERNER, VON BECKERATH NICOLAS, EHRENHAFT ANGELA

ACC 2002
2002

Impact of Angiographic Restenosis Detected by Routine Angiographic Follow-Up at Six Months on Long-Term Mortality
KASTRATI ADNAN, MEHILLI JULINDA, DIRSCHINGER JOSEF, SCHOMIG ALBERT, SCHUHLEN HELMUT, HAUSLEITER JORG, EIMANNSBERGER VERONIKA

ACC 2002
2002

Smoking and Restenosis After Coronary Artery Stenting: The Artifact of Smoker's Paradox
KASTRATI ADNAN, MEHILLI JULINDA, DIRSCHINGER JOSEF, PACHE JURGEN, NEUMANN FRANZ-JOSEF, SCHOMIG ALBERT, SCHUHLEN HELMUT, HOLLE HEIDRUN, DOTZER FRANZ

ACC 2002
2002

Late Angiographic and Clinical Findings After Elective Placement of the Penta Stent: Results From the PENTA Stent Registry
COX DAVID, POPMA JEFFREY J., FARHAT NAIM, MIDEI MARK, SCHOMIG ALEX, HERMILLER JAMES, WERNER JEFFREY, SIEVERS MARINA, FINK STAN, LINNEMEIER TOM

ACC 2002
2002

Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting.
KOCH W, BERGER PB, MEHILLI J, STEPHENSON K, NEUMANN FJ, VON BECKERATH N, BOTTIGER C, DUFF GW, SCHOMIG A

MEDLINE
2000

Restenosis after coronary placement of various stent types.
MEHILLI J, DIRSCHINGER J, PACHE J, ULM K, SCHUHLEN H, SEYFARTH M, SCHMITT C, BLASINI R, NEUMANN FJ, SCHOMIG A

MEDLINE
2001

Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement.
SEYFARTH M, MULLER I, RUDIGER S, POGATSA-MURRAY G, WOLF B, SCHOMIG A

MEDLINE
2001

Sustained benefit over four years from an initial combined antiplatelet regimen after coronary stent placement in the ISAR trial. Intracoronary Stenting and Antithrombotic Regimen.
KASTRATI A, PACHE J, DIRSCHINGER J, SCHOMIG A

MEDLINE
2001

Usefulness of intracoronary brachytherapy for in-stent restenosis with a 188Re liquid-filled balloon.
EIGLER N, WHITING JS, HAUBNER R, HAUSLEITER J, DIRSCHINGER J, KASTRATI A, SCHWAIGER M, SCHOMIG A

MEDLINE
2001

Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: Detection of FK506-binding protein 12 upregulation.
KLEIN CA, RICHTER T, BRANDL R, MURR A, NUHRENBERG T, SCHOMIG A, BAEUERLE PA, NEUMANN FJ

MEDLINE
2001

Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting.
HOCHHOLZER W, POGATSA-MURRAY G, SCHOMIG A, GAWAZ M

MEDLINE
2001

Glycoprotein Ia C807T polymorphism and risk of restenosis following coronary stenting.
KOCH W, MEHILLI J, BOTTIGER C, BRAUN S, SCHOMIG A, KASTRATI A

MEDLINE
2001

Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial.
MEHILLI J, DIRSCHINGER J, DOTZER F, SCHUHLEN H, NEUMANN FJ, FLECKENSTEIN M, PFAFFEROTT C, SEYFARTH M, SCHOMIG A

MEDLINE
2001

Images in cardiology: Structural failure of a coronary stent.
SCHUHLEN H, KASTRATI A, SCHOMIG A

MEDLINE
2001

Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement: analysis of 5,678 patients with a four-week ticlopidine regimen.
KASTRATI A, PACHE J, DIRSCHINGER J, SCHOMIG A

MEDLINE
2001

Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial.
KASTRATI A, MIETHKE T, POGATSA-MURRAY G, MEHILLI J, VALINA C, JOGETHAEI N, DA COSTA CP, WAGNER H, SCHOMIG A

MEDLINE
2001

Previous cytomegalovirus infection and restenosis after coronary stent placement.
KASTRATI A, MIETHKE T, MEHILLI J, POGATSA-MURRAY G, KOCH W, SEYFARTH M, SCHOMIG A

MEDLINE
2001

Clopidogrel therapy in patients undergoing coronary stenting: value of a high loading dose regimen
BRAUN S., DIRSCHINGER J., GAWAZ M., KASTRATI A., MEHILLI J., NEUMANN F.J., SCHOMIG A., SEYFARTH M.

ESC 2001
2001

Polymorphisms of the genes encoding interleukin-10 and tumour necrosis factor have no influence on clinical outcome and angiographic restenosis after coronary artery stenting
KASTRATI A., KIEMOSER D., KOCH W., MEHILLI J., REDL A., SCHOMIG A.

ESC 2001
2001

Is stenting superior to PTCA for lesions in small coronary arteries in diabetic patients? Results from the ISAR-SMART randomized trial
DIRSCHINGER J., DOTZER F., FLECKENSTEIN M., KASTRATI A., MEHILLI J., NEUMANN F.J., PACHE J., SCHMITT C., SCHOMIG A.

ESC 2001
2001

The 894G/T polymorphism of the gene encoding endothelial constitutive nitric oxide synthase is associated with an adverse outcome after coronary stenting
GORTCHAKOVA O., KASTRATI A., KOCH W., MEHILLI J., SCHOMIG A., VON BECKERATH N.

ESC 2001
2001

Statin treatment following coronary artery stenting and 1-year survival
BOLLWEIN H., DIRSCHINGER J., GEISSLER B., HOLLE H., HOSL K., KASTRATI A., KASTRATI D., MEHILLI J., PACHE J., SCHOMIG A.

ESC 2001
2001

Glycoprotein Ia C807T Polymorphism and Risk of Restenosis Following Coronary Artery Stenting
BECKERATH NICOLAS VON, BOTTIGER CORINNA, BRAUN SIEGMUND, KASTRATI. ADNAN, KOCH WERNER, MEHILLI JULINDA, SCHOMIG ALBERT

ACC 2001
2001

Endothelial Nitric Oxide Synthase Gene 894GT Polymorphism Is Associated With an Adverse Outcome After Coronary Stenting
BECKERATH NICOLAS VON, GORTCHAKOVA OLLGA, KASTRATI. ADNAN, KOCH WERNER, MEHILLI JULINDA, SCHOMIG ALBERT

ACC 2001
2001

Previous cytomegalovirus infection and risk of coronary thrombotic events after stent placement.
NEUMANN FJ, KASTRATI A, MIETHKE T, POGATSA-MURRAY G, SEYFARTH M, SCHOMIG A

MEDLINE

Primary intracoronary stenting in acute myocardial infarction: long-term clinical and angiographic follow-up and risk factor analysis.
KASTRATI A, PACHE J, DIRSCHINGER J, NEUMANN FJ, WALTER H, SCHMITT C, SCHOMIG A

MEDLINE
2000

G protein beta3 subunit polymorphism and risk of thrombosis and restenosis following coronary stent placement.
VON BECKERATH N, KASTRATI A, KOCH W, BOTTIGER C, MEHILLI J, SEYFARTH M, SCHOMIG A

MEDLINE
2000

Genetic risk factors and restenosis after percutaneous coronary interventions [published erratum appears in Herz 2000 Mar;25(2):153]
KASTRATI A, DIRSCHINGER J, SCHOMIG A

MEDLINE
2000

Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction.
NEUMANN FJ, KASTRATI A, SCHMITT C, BLASINI R, HADAMITZKY M, MEHILLI J, GAWAZ M, SCHLEEF M, SEYFARTH M, DIRSCHINGER J, SCHOMIG A

MEDLINE
2000

Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting.
VON BECKERATH N, KOCH W, MEHILLI J, BOTTIGER C, SCHOMIG A, KASTRATI A

MEDLINE
2000

Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease.
KASTRATI A, SCHOMIG A, DIRSCHINGER J, MEHILLI J, VON WELSER N, PACHE J, SCHUHLEN H, SCHILLING T, SCHMITT C, NEUMANN FJ

MEDLINE
2000

1 2